[Immune mechanisms of hepatoprotector effects of etomersol and thymogen].
Okovityĭ. S V SV; Gaĭvoronskaia. V V VV
Key Findings
- Thymogen’s liver‑protective effect depends on an intact thymus
- Even without a thymus, thymogen still stimulates antibody‑forming cells in the spleen
- Etomerzol, another drug, shows similar immune‑modulating actions without affecting healthy animals
Practical Outcomes
- For biohackers, thymogen may be useful as an immune‑support supplement, but there’s no clear dosing or protocol for liver protection in humans. Its benefits likely come from overall immune modulation, so it’s not a direct, actionable liver‑protective hack at this stage.
Summary
The study shows that the peptide thymogen can boost certain immune functions and help protect the liver, but only when the thymus gland is present. In animals without a thymus, its liver‑protecting effect disappears, though it still helps make more antibody‑producing cells in the spleen. This suggests thymogen works mainly by modulating the immune system rather than acting directly on the liver.
Abstract
The reparation-regeneration effects of the actoprotector etomerzol and the immunomodulant thymogen can be mediated by certain units of the immune system, in particular, by thymus. Both thymogen and etomerzol loss the hepatoprotector activity on the background of thymectomy, but still produce an immunomodulant effect by stimulating the production of antibody-forming cells in the spleen in response to changes in the immune system induced by various stressor factors (thymectomy, hepatectomy, or their combination). This property of etomerzol, together with the absence of influence upon the immune state of intact experimental animals, is evidence of a dominating immunomodulant activity of this drug.
Study Information
pubmed
2002